News
-
-
PRESS RELEASE
Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
Moderna reports 8-fold increase in neutralizing antibodies with Spikevax 2025-2026 formula, reinforcing FDA approval. Clinical trial data supports efficacy against COVID-19 LP.8.1 variant -
-
PRESS RELEASE
EQS-Adhoc: DEAG Deutsche Entertainment Aktiengesellschaft: DEAG opts to issue bonds of up to EUR 75 million to refinance the Corporate Bond 2023/2026 and continue its expansion throughout Europe
DEAG Deutsche Entertainment Aktiengesellschaft opts to issue bonds of up to EUR 75 million to refinance the Corporate Bond 2023/2026 and continue expansion throughout Europe -
-
-
-
-
-